Results for "firb"
131-140 of 223 results for 'firb'
Corporate law developments
Welcome to the first edition of Nucleus our monthly snapshot of regulatory updates and other developments in corporate law We know you are busy so our focus is on capturing key issues ...
Allens advises Dixon Hospitality on buy-out by KKR
Allens has advised Dixon Hospitality on its buy-out by funds or accounts managed or advised by Kohlberg Kravis Roberts & Co. L.P. or its affiliates (KKR). A multidisciplinary team spanning Allens' ...
Opportunities for financial services from the China-Australia FTA
The Australian and Chinese governments recently announced the conclusion of negotiations on the China Australia Free Trade Agreement According to DFAT Chinas financial services commitments under the agreement represent one of the most substantial market access undertakings China has agreed to with ...
Allens advises EBOS Group on acquisition of HPS
Allens has advised EBOS Group Limited on the proposed purchase of HPS, Australia's largest provider of outsourced pharmacy services. The acquisition of HPS - from Blue Sky Private Equity and a numb ...
PE Horizons 2024 mid-year update: readying for a wave of exits
So what's keeping PE dealmakers busy? The big focus continues to be on exits as conditions improve and pressure mounts to return capital to investors. Corporate carve-outs are still popular and debt is well and truly back, with private credit now in the spotlight. ...
Corporate law developments
Welcome to our monthly snapshot of regulatory updates and other developments in corporate law We know you are busy so our focus is on capturing key issues ...
Allens advises Keppel Infrastructure Trust on $1.1bn acquisition of Ixom
Allens has advised Keppel Infrastructure Trust (KIT) on its acquisition of leading chemicals business Ixom for an enterprise value of $1.1 billion. The acquisition, from Blackstone managed funds an ...
Allens advises Healthscope on sale of Australian pathology business
Allens has acted for one of Australia's leading private healthcare operators, Healthscope Limited, on the sale of its Australian pathology operations to Crescent Capital Partners for $105 million. ...
Corporate law developments
Welcome to our monthly snapshot of regulatory updates and other developments in corporate law We know you are busy so our focus is on capturing key issues ...
Nucleus – corporate law developments: ASIC restricts effectiveness of certain director resignations; new ASIC whistleblower immunity policy; and other updates
ASIC restricts effectiveness of director resignations and introduces new whistleblower immunity policy; FIRB commences evaluation of changes to foreign investment laws; ACCC flags further reform of merger review process in 2021; lapsing of electronic signing and virtual meeting protocols ...